ID: ALA5275635

Max Phase: Preclinical

Molecular Formula: C19H18O4

Molecular Weight: 310.35

Associated Items:

Representations

Canonical SMILES:  CCC(c1ccccc1)c1c(O)c2ccc(OC)cc2oc1=O

Standard InChI:  InChI=1S/C19H18O4/c1-3-14(12-7-5-4-6-8-12)17-18(20)15-10-9-13(22-2)11-16(15)23-19(17)21/h4-11,14,20H,3H2,1-2H3

Standard InChI Key:  CCPGCKQLIHGSCJ-UHFFFAOYSA-N

Associated Targets(non-human)

Human immunodeficiency virus type 1 protease 9113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 310.35Molecular Weight (Monoisotopic): 310.1205AlogP: 4.05#Rotatable Bonds: 4
Polar Surface Area: 59.67Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.62CX Basic pKa: CX LogP: 3.58CX LogD: 1.83
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.74Np Likeness Score: 0.24

References

1. Hassan MZ, Osman H, Ali MA, Ahsan MJ..  (2016)  Therapeutic potential of coumarins as antiviral agents.,  123  [PMID:27484512] [10.1016/j.ejmech.2016.07.056]

Source